verapamil has been researched along with octaarginine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, CC; Lü, HX; Zhang, YL; Zhang, ZH; Zhou, JP | 1 |
Gao, H; He, Q; Liu, Y; Ran, R; Tang, J; Zhang, L; Zhang, Q; Zhang, Z | 1 |
2 other study(ies) available for verapamil and octaarginine
Article | Year |
---|---|
[In situ rat intestine absorption of paclitaxel-loaded solid lipid nanoparticles modified with cell-penetrating peptides].
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell-Penetrating Peptides; Drug Carriers; Intestinal Absorption; Lipids; Male; Nanoparticles; Oligopeptides; Paclitaxel; Perfusion; Rats; Rats, Sprague-Dawley; Stearic Acids; Verapamil | 2013 |
Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Clathrin; Doxorubicin; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Liposomes; MCF-7 Cells; Oligopeptides; Verapamil | 2016 |